Skip to content

Company information lookup

TISSUE THERAPIES LIMITED (TIS)

Developing biomedical technologies for wound healing and tissue and cell culture.

On this page you will find:

Delayed share price
Company announcements
Price history chart
Exchange Traded Options
ASX-Listed Emblem Company details
Closing prices
Dividends
Warrants & Structured Products
ASX CFDs

Delayed share price

Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.

Code Last % Chg Bid Offer Open High Low Vol
TIS 0.355 5.97% 0.360 0.365 0.335 0.365 0.335 833,906

TISSUE THERAPIES LIMITED details

Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code TIS
Securities
Official Listing Date 19 March, 2004
GICS Industry Group Pharmaceuticals, Biotechnology & Life Sciences
Exempt Foreign? No
Internet Address http://www.tissuetherapies.com
Registered Office Address Level 19, 179 Turbot Street, BRISBANE, QLD, AUSTRALIA, 4000
Head Office Telephone 07 3334 3900
Head Office Fax 07 3334 3999
Share Registry LINK MARKET SERVICES LIMITED
LEVEL 15, 324 QUEEN STREET, BRISBANE, QLD, AUSTRALIA, 4000
Share Registry Telephone 1300 554 474
Directors / Senior Management
Mr Roger Clarke (Chairman)
Dr Steven Mercer (CEO, Director)
Mr Mel Bridges (Director)
Dr Cherrell Hirst (Director)
Mr Iain Ross (Director)
Company Secretary Mr Drummond McKenzie
Principal Activities Developing biomedical technologies for wound healing and tissue and cell culture.

TISSUE THERAPIES LIMITED announcements

How are company announcements published on www.asx.com.au?

Date Price
sens.
Headline Pages PDF
19/08/2014 asterix Appendix 4E for YE 30 June 2014 2 PDF
19/08/2014   Directors' Report & Financial Report for YE 30 June 2014 44 PDF
28/07/2014 asterix Response Lodged to EMA Review Questions 2 PDF
23/07/2014 asterix Appendix 4C - quarterly 5 PDF
19/06/2014   Change of Director's Interest Notice- Iain Ross 2 PDF
16/04/2014 asterix Appendix 4C - March 2014 Quarter 5 PDF
08/04/2014   Appendix 3B 13 PDF
06/03/2014   Change of Director's Interest Notice - Mel Bridges 2 PDF
04/03/2014   Change of Director's Interest Notice- Mel Bridges 2 PDF
03/03/2014   CEO Presentation to ASX Spotlight Conference 6 March 2014 20 PDF

> search for past company announcements

Viewing Market Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date Last % Change High Low Vol *
22 Aug 2014 0.355 5.97% 0.365 0.335 833,906
21 Aug 2014 0.335 6.35% 0.335 0.315 229,714
20 Aug 2014 0.315 -1.56% 0.325 0.310 242,563
19 Aug 2014 0.320 6.67% 0.320 0.300 175,952
18 Aug 2014 0.300 -6.25% 0.315 0.300 350,416

* Volume of shares shown represents only those shares traded on ASX.

TISSUE THERAPIES LIMITED price history chart

* More charting options are available.

Dividends

How are dividends released on www.asx.com.au?

No dividends have been found for the security TIS. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.

Exchange Traded Options

No Exchange Traded Options are available over the security TIS

Warrants & Structured Products

No warrants & Structured Products are available over the security TIS

ASX CFDs

No Contracts For Differences are available over the security TIS